Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)

CUSIP: 501147102

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+2,561,053
Put/Call ratio
33%
SEC-reported price per share
$77.04
Number of holders
113
Value change
+$201,515,888
Number of buys
67
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
29,463,330

Security key

501147102

Report period

Q1 2021

Institutions

113

Top holders

10

Ownership snapshot

Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Redmile Group, LLC
Disclosed value leader
Redmile Group, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F Lead comparable stake: 5.7% Showing 1-6 of 15 holder rows.

Quick read

Redmile Group, LLC leads the comparable SEC ownership view at 5.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Redmile Group, LLC's linked filing trail.
Comparable ownership Top 5
Redmile Group, LLC 5.7%
BlackRock Finance, Inc. 4.8%
FMR LLC 4.3%
FRAZIER MANAGEMENT LLC 3%
CREDIT SUISSE AG/ 2.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Redmile Group, LLC
13F
Company
13F
5.7%
$100,502,000
1,675,036 shares
31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
4.8%
$84,441,000
1,407,348 shares
31 Dec 2020
FMR LLC
13F
Company
13F
4.3%
$75,143,000
1,252,386 shares
31 Dec 2020
FRAZIER MANAGEMENT LLC
13F
Company
13F
3%
$53,700,000
895,000 shares
31 Dec 2020
CREDIT SUISSE AG/
13F
Company
13F
2.6%
$46,532,000
775,528 shares
31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
2.5%
$44,347,000
739,138 shares
31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
113
Shares
16,474,358
Rows available
113
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
107
Q1 2021 holders
113
Holder diff
6
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .